首页> 美国卫生研究院文献>The Clinical Biochemist Reviews >Real-time and Label-free Bio-sensing of Molecular Interactions by Surface Plasmon Resonance: A Laboratory Medicine Perspective
【2h】

Real-time and Label-free Bio-sensing of Molecular Interactions by Surface Plasmon Resonance: A Laboratory Medicine Perspective

机译:通过表面等离振子共振的分子相互作用的实时和无标签生物传感:实验室医学的角度。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Radioactive, chromogenic, fluorescent and other labels have long provided the basis of detection systems for biomolecular interactions including immunoassays and receptor binding studies. However there has been unprecedented growth in a number of powerful label free biosensor technologies over the last decade. While largely at the proof-of-concept stage in terms of clinical applications, the development of more accessible platforms may see surface plasmon resonance (SPR) emerge as one of the most powerful optical detection platforms for the real-time monitoring of biomolecular interactions in a label-free environment.In this review, we provide an overview of SPR principles and current and future capabilities in a diagnostic context, including its application for monitoring a wide range of molecular markers of disease. The advantages and pitfalls of using SPR to study biomolecular interactions are discussed, with particular emphasis on its potential to differentiate subspecies of analytes and the inherent ability for quantitation through calibration-free concentration analysis (CFCA). In addition, recent advances in multiplex applications, high throughput arrays, miniaturisation, and enhancements using noble metal nanoparticles that promise unprecedented sensitivity to the level of single molecule detection, are discussed.In summary, while SPR is not a new technique, technological advances may see SPR quickly emerge as a highly powerful technology, enabling rapid and routine analysis of molecular interactions for a diverse range of targets, including those with clinical applicability. As the technology produces data quickly, in real-time and in a label-free environment, it may well have a significant presence in future developments in lab-on-a-chip technologies including point-of-care devices and personalised medicine.
机译:放射性,生色,荧光和其他标记物长期以来一直为生物分子相互作用的检测系统提供基础,包括免疫测定和受体结合研究。然而,在过去十年中,许多强大的无标记生物传感器技术有了空前的增长。尽管在临床应用方面主要处于概念验证阶段,但更易于访问的平台的开发可能会看到表面等离振子共振(SPR)成为实时监测生物分子相互作用的最强大的光学检测平台之一。在本文中,我们概述了SPR原理以及在诊断环境中当前和将来的功能,包括其在监测多种疾病分子标记中的应用。讨论了使用SPR研究生物分子相互作用的优势和陷阱,尤其着重于其区分分析物亚种的潜力以及通过无标定浓度分析(CFCA)进行定量分析的固有能力。此外,还讨论了多元应用,高通量阵列,小型化和使用贵金属纳米粒子的增强技术的最新进展,这些技术有望对单分子检测水平提供前所未有的灵敏度。总之,尽管SPR并不是一项新技术,但技术进步可能看到SPR迅速成为一种非常强大的技术,可以对各种目标(包括具有临床适用性的目标)进行分子相互作用的快速和常规分析。由于该技术可以在实时,无标签的环境中快速生成数据,因此很可能会在包括护理点设备和个性化医疗在内的芯片实验室技术的未来发展中占有重要地位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号